BM
Meyer, Benjamin
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal |  | 2024 | 28 | 31 | ||
| SARS-CoV-2 viral load and shedding kinetics | Nature reviews. Microbiology | | 2023 | 148 | 77 | ||
| Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatus | PloS one | | 2023 | 81 | 23 | ||
| SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses | EBioMedicine | | 2023 | 66 | 54 | ||
| Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | | 2023 | 153 | 21 | ||
| Influence of circadian clocks on adaptive immunity and vaccination responses | Nature communications | | 2023 | 227 | 45 | ||
| Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | | 2022 | 132 | 79 | ||
| Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva | Epidemics | | 2022 | 157 | 52 | ||
| Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | | 2022 | 88 | 24 | ||
| Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 62 | 0 | |||
| Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature | | 2022 | 1,383 | 188 | ||
| Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | | 2022 | 372 | 86 | ||
| COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | | 2022 | 72 | 50 | ||
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | | 2022 | 227 | 118 | ||
| Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature medicine | | 2022 | 209 | 70 | ||
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | | 2022 | 147 | 70 | ||
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | | 2021 | 345 | 121 | ||
| SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 272 | 38 | |||
| Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | | 2021 | 350 | 176 | ||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | | 2021 | 476 | 269 | ||
| Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | | 2021 | 244 | 88 | ||
| Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort study | Infection Control and Hospital Epidemiology | | 2021 | 261 | 152 | ||
| Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | | 2021 | 240 | 195 | ||
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | | 2021 | 352 | 169 | ||
| Waning antibodies to SARS-CoV-2 - Don't panic | The Lancet Regional Health. Europe | | 2021 | 141 | 59 | ||
| Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana | One Health Outlook | | 2021 | 208 | 74 | ||
| SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | | 2021 | 341 | 221 | ||
| A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples | Proceedings of the National Academy of Sciences | | 2021 | 260 | 115 | ||
| Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | | 2021 | 584 | 112 | ||
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | | 2021 | 291 | 135 | ||
| Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT) | Emerging Microbes & Infections | | 2020 | 364 | 128 | ||
| Validation of a commercially available SARS-CoV-2 serological immunoassay | Clinical Microbiology and Infection | | 2020 | 454 | 237 | ||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet |  | 2020 | 698 | 14 | ||
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | | 2020 | 394 | 314 | ||
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | | 2020 | 334 | 160 | ||
| SARS-CoV-2 seroprevalence in COVID-19 hotspots | The Lancet | | 2020 | 305 | 86 | ||
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | | 2020 | 448 | 175 | ||
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | | 2020 | 212 | 94 | ||
| Link of a ubiquitous human coronavirus to dromedary camels | Proceedings of the National Academy of Sciences of the United States of America | | 2016 | 159 | 94 |
